Transmembrane communication: General principles and lessons from the structure and function of the M2 proton channel, K+ channels, and integrin receptors

Annual Review of Biochemistry

Volumn 80, Issue , 2011, Pages 211-237

  Grigoryan, Gevorg ^a   Moore, David T ^a   Degrado, William F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

allostery; ion channel; receptor; signal transduction; transmembrane signaling

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; INTEGRIN RECEPTOR; PROTEIN M2; VOLTAGE GATED POTASSIUM CHANNEL;

ALLOSTERISM; ALPHA CHAIN; ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BETA CHAIN; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHANNEL GATING; CHEMICAL MODEL; CONFORMATIONAL TRANSITION; CROSS COUPLING REACTION; HUMAN; INTRACELLULAR SIGNALING; LIGAND BINDING; MICROENVIRONMENT; MOLECULAR MODEL; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; THERMODYNAMICS;

CELL COMMUNICATION; CELL MEMBRANE; INTEGRINS; IONS; LIGANDS; MODELS, MOLECULAR; POTASSIUM CHANNELS; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; THERMODYNAMICS; VIRAL MATRIX PROTEINS;

BACTERIA (MICROORGANISMS); INFLUENZA A VIRUS;

EID: 79959429680     PISSN: 00664154     EISSN: 00664154     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-091008-152423     Document Type: Article

References (151)

1. Csermely P, PalotaiR, NussinovR. 2010. Induced fit, conformational selection and independent dynamic segments: an extended view of binding events. Trends Biochem. Sci. 35:539-546.
2. Monod J. 1966. From enzymatic adaptation to allosteric transitions. Science 154:475-483.
3. Monod J, Wyman J, Changeux JP. 1965. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12:88-118.
4. Boehr DD, Nussinov R, Wright PE. 2009. The role of dynamic conformational ensembles in biomolecular recognition. Nat. Chem. Biol. 5:789-796.
5. KoshlandDE Jr, NemethyG, Filmer D. 1966. Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry 5:365-385.
6. Hill AV. 1922. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J. Physiol. 40:iv-vii.
7. Liu Z, Gandhi CS, Rees DC. 2009. Structure of a tetrameric MscL in an expanded intermediate state. Nature 461:120-124.
8. Schmidt D, Cross SR, MacKinnon R. 2009. A gating model for the archeal voltage-dependent K+ channel KvAP in DPhPC and POPE:POPG decane lipid bilayers. J. Mol. Biol. 390:902-912.
9. Schmidt D, Jiang QX, MacKinnon R. 2006. Phospholipids and the origin of cationic gating charges in voltage sensors. Nature 444:775-779. (Pubitemid 44949608)
10. Nishida M, Cadene M, Chait BT, MacKinnon R. 2007. Crystal structure of a Kir3.1-prokaryotic Kir channel chimera. EMBO J. 26:4005-015. (Pubitemid 47367496)
11. Luo W, Cady SD, Hong M. 2009. Immobilization of the influenza A M2 transmembrane peptide in virus envelope-mimetic lipid membranes: a solid-state NMR investigation. Biochemistry 48:6361-368.
12. Schroeder C, Heider H, Moncke-Buchner E, Lin TI. 2005. The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein. Eur. Biophys. J. 34:52-66. (Pubitemid 40238919)
13. SchroederC. 2010. Cholesterol-binding viral proteins in virus entry andmorphogenesis. Subcell. Biochem. 51:77-108.
14. Zagotta WN, Hoshi T, Aldrich RW. 1994. Shaker potassium channel gating. III: Evaluation of kinetic models for activation. J. Gen. Physiol. 103:321-362. (Pubitemid 24068562)
15. Lin YH, Gao R, Binns AN, Lynn DG. 2008. Capturing the VirA/VirGTCS of Agrobacterium tumefaciens. Adv. Exp. Med. Biol. 631:161-177.
16. Hille B. 1992. Ionic Channels of Excitable Membranes. Sunderland, MA: Sinauer.
17. Gouaux E, Mackinnon R. 2005. Principles of selective ion transport in channels and pumps. Science 310:1461-465. (Pubitemid 41746336)
18. MacKinnon R. 2003. Potassium channels. FEBS Lett. 555:62-65. (Pubitemid 37431098)
19. Cady SD, Schmidt-Rohr K, WangJ, Soto CS, DeGradoWF, HongM. 2010. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature 463:689-692.
20. Zhou HX. 2010. Diffusion-influenced transport of ions across a transmembrane channel with an internal binding site. J. Phys. Chem. Lett. 1:1973-976.
21. Panyi G, Deutsch C. 2007. Probing the cavity of the slow inactivated conformation of shaker potassium channels. J. Gen. Physiol. 129:403-418. (Pubitemid 46686456)
22. Ray EC, Deutsch C. 2006. A trapped intracellular cation modulates K+ channel recovery from slow inactivation. J. Gen. Physiol. 128:203-217. (Pubitemid 44156758)
23. Cuello LG, Jogini V, Cortes DM, Perozo E. 2010. Structural mechanism of C-type inactivation in K+ channels. Nature 466:203-8.
24. Cuello LG, Jogini V, Cortes DM, Pan AC, Gagnon DG, et al. 2010. Structural basis for the coupling between activation and inactivation gates in K+ channels. Nature 466:272-275.
25. Cuello LG, Cortes DM, Jogini V, Sompornpisut A, Perozo E. 2010. Amolecular mechanism for protondependent gating in KcsA. FEBS Lett. 584:1126-132.
26. Imai S, Osawa M, Takeuchi K, Shimada I. 2010. Structural basis underlying the dual gate properties of KcsA. Proc. Natl. Acad. Sci. USA 107:6216-221.
27. Rotem D, Mason A, Bayley H. 2010. Inactivation of the KcsA potassium channel explored with heterotetramers. J. Gen. Physiol. 135:29-42.
28. Miloshevsky GV, Jordan PC. 2007. Open-state conformation of the KcsA K+ channel: Monte Carlo normal mode following simulations. Structure 15:1654-662. (Pubitemid 350218214)
29. Haliloglu T, Ben-Tal N. 2008. Cooperative transition between open and closed conformations in potassium channels. PLoS Comput. Biol. 4:e1000164.
30. Shimizu H, Iwamoto M, Konno T, Nihei A, Sasaki YC, Oiki S. 2008. Global twisting motion of single molecular KcsA potassium channel upon gating. Cell 132:67-78.
31. Ader C, Schneider R, Hornig S, Velisetty P, Vardanyan V, et al. 2009. Coupling of activation and inactivation gate in a K+-channel: potassium and ligand sensitivity. EMBO J. 28:2825-834.
32. Alam A, Jiang Y. 2009. High-resolution structure of the open NaK channel. Nat. Struct. Mol. Biol. 16:30-34.
33. Uysal S, Vasquez V, Tereshko V, Esaki K, Fellouse FA, et al. 2009. Crystal structure of full-length KcsA in its closed conformation. Proc. Natl. Acad. Sci. USA 106:6644-649.
34. Zhao LL, WuA, Bi LJ, Liu P, Zhang XE, et al. 2009. Length-dependent regulation of the Kv1.2 channel activation by its C-terminus. Mol. Membr. Biol. 26:186-193.
35. Sharma M, Yi M, Dong H, Qin H, Peterson E, et al. 2010. Insight into the mechanism of the influenza A proton channel from a structure in a lipid bilayer. Science 330:509-512.
36. Hu F, Luo W, Hong M. 2010. Mechanisms of proton conduction and gating in influenza M2 proton channels from solid-state NMR. Science 330:505-8.
37. Stouffer AL, Acharya R, SalomD, Levine AS, DiCostanzo L, et al. 2008. Structural basis for the function and inhibition of an influenza virus proton channel. Nature 451:596-599. (Pubitemid 351186271)
38. Schnell JR, Chou JJ. 2008. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451:591-595. (Pubitemid 351186272)
39. Acharya A, Carnevale V, Fiorin G, Levine BG, Polishchuk A, et al. 2010. Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc. Natl. Acad. Sci. USA 107:15075-080.
40. Acharya R, Carnevale V, Fiorin G, Levine BG, Polishchuk AL, et al. 2010. Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc. Natl. Acad. Sci. USA 107:15075-080.
41. Pinto LH, Lamb RA. 2006. Influenza virus proton channels. Photochem. Photobiol. Sci. 5:629-632. (Pubitemid 43885927)
42. Rossman JS, Lamb RA. 2009. Autophagy, apoptosis, and the influenza virus M2 protein. CellHostMicrobe 6:299-300.
43. Rossman JS, Jing X, Leser GP, Lamb RA. 2010. Influenza virus M2 protein mediates ESCRTindependent membrane scission. Cell 142:902-913.
44. Gannage M, Dormann D, Albrecht R, Dengjel J, Torossi T, et al. 2009. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 6:367-380.
45. Park EK, Castrucci MR, Portner A, Kawaoka Y. 1998. The M2 ectodomain is important for its incorporation into influenza A virions. J. Virol. 72:2449-455. (Pubitemid 28100806)
46. Ma C, Polishchuk AL, Ohigashi Y, Stouffer AL, Schon A, et al. 2009. Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel. Proc. Natl. Acad. Sci. USA 106:12283-288.
47. Kochendoerfer GG, SalomD, Lear JD, Wilk-Orescan R, Kent SB, DeGrado WF. 1999. Total chemical synthesis of the integral membrane protein influenza A virus M2: role of its C-terminal domain in tetramer assembly. Biochemistry 38:11905-913.
48. SalomD, Hill BR, Lear JD, DeGradoWF. 2000. pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus. Biochemistry 39:14160-170.
49. Cady SD, Luo W, Hu F, Hong M. 2009. Structure and function of the influenza A M2 proton channel. Biochemistry 48:7356-364.
50. McCown MF, Pekosz A. 2006. Distinct domains of the influenza A virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. J. Virol. 80:8178-189. (Pubitemid 44182318)
51. Balannik V, Carnevale V, Fiorin G, Levine BG, Lamb RA, et al. 2010. Functional studies and modeling of pore-lining residue mutants of the influenza A virus M2 ion channel. Biochemistry 49:696-708.
52. Jing X, Ma C, Ohigashi Y, Oliveira FA, Jardetzky TS, et al. 2008. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. Proc. Natl. Acad. Sci. USA 105:10967-972.
53. Ohigashi Y, Ma C, Jing X, Balannick V, Pinto LH, Lamb RA. 2009. An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition. Proc. Natl. Acad. Sci. USA 106:18775-779.
54. Rossman JS, Jing X, Leser GP, Balannik V, Pinto LH, Lamb RA. 2010. Influenza virus M2 ion channel protein is necessary for filamentous virion formation. J. Virol. 84:5078-088.
55. Hu J, AsburyT, Achuthan S, LiC, Bertram R, et al. 2007. Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from influenza A virus. Biophys. J. 92:4335-343. (Pubitemid 46915327)
56. Pielak RM, Chou JJ. 2010. Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel. Biochem. Biophys. Res. Commun. 401:58-63.
57. Zhou Y, MacKinnon R. 2003. The occupancy of ions in the K+ selectivity filter: charge balance and coupling of ion binding to a protein conformational change underlie high conduction rates. J. Mol. Biol. 333:965-975. (Pubitemid 37324499)
58. Zhou Y, Morais-Cabral JH, Kaufman A, MacKinnon R. 2001. Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 A resolution. Nature 414:43-48. (Pubitemid 33041616)
59. Lockless SW, Zhou M, MacKinnon R. 2007. Structural and thermodynamic properties of selective ion binding in a K+ channel. PLoS Biol. 5:e121.
60. Zhou M, MacKinnon R. 2004. A mutant KcsA K+ channel with altered conduction properties and selectivity filter ion distribution. J. Mol. Biol. 338:839-846. (Pubitemid 38507426)
61. Morais-Cabral JH, Zhou Y, MacKinnon R. 2001. Energetic optimization of ion conduction rate by the K+ selectivity filter. Nature 414:37-42.
62. Berneche S, Roux B. 2001. Energetics of ion conduction through the K+ channel. Nature 414:73-77. (Pubitemid 33041625)
63. Egwolf B, Roux B. 2010. Ion selectivity of the KcsA channel: a perspective from multi-ion free energy landscapes. J. Mol. Biol. 401:831-842.
64. Dixit PD, Merchant S, Asthagiri D. 2009. Ion selectivity in the KcsA potassium channel from the perspective of the ion binding site. Biophys. J. 96:2138-145.
65. Domene C, Furini S. 2009. Dynamics, energetics, and selectivity of the low-K+ KcsA channel structure. J. Mol. Biol. 389:637-645.
66. Kraszewski S, BoiteuxC, RamseyerC, GirardetC. 2009. Determination of the charge profile in theKcsA selectivity filter using ab initio calculations and molecular dynamics simulations. Phys. Chem. Chem. Phys. 11:8606-613.
67. Thompson AN, Kim I, Panosian TD, Iverson TM, Allen TW, Nimigean CM. 2009. Mechanism of potassium-channel selectivity revealed by Na+ and Li+ binding sites within the KcsA pore. Nat. Struct. Mol. Biol. 16:1317-324.
68. Decoursey TE. 2003. Voltage-gated proton channels and other proton transfer pathways. Physiol. Rev. 83:475-579. (Pubitemid 36382892)
69. Mould JA, Li H-C, Dudlak CS, Lear JD, Pekosz A, et al. 2000. Mechanism for proton conduction of the M2 ion channel of influenza A virus. J. Biol. Chem. 275:8592-599. (Pubitemid 30180208)
70. Mould JA, Drury JE, Frings SM, Kaupp UB, Pekosz A, et al. 2000. Permeation and activation of the M2 ion channel of influenza A virus. J. Biol. Chem. 275:31038-050.
71. Leiding T, Wang J, Martinsson J, DeGrado WF, Arskold SP. 2010. Proton and cation transport activity of the M2 proton channel from influenza A virus. Proc. Natl. Acad. Sci. USA 107:15409-414.
72. Chizhmakov IV, Ogden DC, Geraghty FM, Hayhurst A, Skinner A, et al. 2003. Differences in conductance of M2 proton channels of two influenza viruses at low and high pH. J. Physiol. 546:427-438. (Pubitemid 36175978)
73. Czabotar PE, Martin SR, Hay AJ. 2004. Studies of structural changes in the M2 proton channel of influenza A virus by tryptophan fluorescence. Virus Res. 99:57-61. (Pubitemid 37542491)
74. Chizhmakov IV, Geraghty FM, Ogden DC, Hayhurst A, Antoniou M, Hay AJ. 1996. Selective proton permeability and pH regulation of the influenza virusM2 channel expressed in mouse erythroleukaemia cells. J. Physiol. 494:329-336. (Pubitemid 26318773)
75. Wang C, Lamb RA, Pinto LH. 1995. Activation of the M(2) ion channel of influenza virus: a role for the transmembrane domain histidine residue. Biophys. J. 69:1363-371.
76. Hu J, Fu R, Nishimura K, Zhang L, Zhou HX, et al. 2006. Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity. Proc. Natl. Acad. Sci. USA 103:6865-870.
77. Pinto LH, Dieckmann GR, Gandhi CS, Papworth CG, Braman J, et al. 1997. A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc. Natl. Acad. Sci. USA 94:11301-6.
78. Tang Y, Zaitseva F, Lamb RA, Pinto LH. 2002. The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue. J. Biol. Chem. 277:39880-886. (Pubitemid 35190974)
79. Dieckmann GR, McRorie DK, Lear JD, Sharp KA, DeGrado WF, Pecoraro VL. 1998. The role of protonation and metal chelation preferences in defining the properties of mercury-binding coiled coils. J. Mol. Biol. 280:897-912. (Pubitemid 28345023)
80. Chen H, WuY, Voth GA. 2007. Proton transport behavior through the influenza A M2 channel: insights from molecular simulation. Biophys. J. 93:3470-479. (Pubitemid 350190810)
81. Long SB, Tao X, Campbell EB, MacKinnon R. 2007. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature 450:376-382. (Pubitemid 350126743)
82. Cordero-Morales JF, Jogini V, Lewis A, Vasquez V, Cortes DM, et al. 2007. Molecular driving forces determining potassium channel slow inactivation. Nat. Struct. Mol. Biol. 14:1062-069. (Pubitemid 350060332)
83. Ader C, Schneider R, Hornig S, Velisetty P, WilsonEM, et al. 2008.Astructural link between inactivation and block of a K+ channel. Nat. Struct. Mol. Biol. 15:605-612. (Pubitemid 351799137)
84. Chakrapani S, Cordero-Morales JF, Perozo E. 2007. A quantitative description of KcsA gating II: singlechannel currents. J. Gen. Physiol. 130:479-496. (Pubitemid 350036735)
85. Chakrapani S, Cordero-Morales JF, Perozo E. 2007. A quantitative description of KcsA gating I: macroscopic currents. J. Gen. Physiol. 130:465-478. (Pubitemid 350036734)
86. Grigoryan G, DeGrado WF. 2011. Probing designability via a generalized model of helical bundle geometry. J. Mol. Biol. 405(4):1079-100.
87. Bucher D, GuidoniL, Rothlisberger U. 2007. The protonation state of the Glu-71/Asp-80 residues in the KcsA potassium channel: a first-principles QM/MM molecular dynamics study. Biophys. J. 93:2315-324. (Pubitemid 47511131)
88. Thompson AN, Posson DJ, Parsa PV, Nimigean CM. 2008. Molecular mechanism of pH sensing in KcsA potassium channels. Proc. Natl. Acad. Sci. USA 105:6900-5. (Pubitemid 351754502)
89. Blunck R, McGuire H, Hyde HC, Bezanilla F. 2008. Fluorescence detection of the movement of single KcsA subunits reveals cooperativity. Proc. Natl. Acad. Sci. USA 105:20263-268.
90. Perozo E, Kloda A, Cortes DM, Martinac B. 2001. Site-directed spin-labeling analysis of reconstituted Mscl in the closed state. J. Gen. Physiol. 118:193-206.
91. Cortes DM, Cuello LG, Perozo E. 2001. Molecular architecture of full-length KcsA: role of cytoplasmic domains in ion permeation and activation gating. J. Gen. Physiol. 117:165-180. (Pubitemid 32423754)
92. Yuchi Z, Pau VP, Lu BX, Junop M, Yang DS. 2009. An engineered right-handed coiled coil domain imparts extreme thermostability to the KcsA channel. FEBS J. 276:6236-246.
93. Hirano M, Takeuchi Y, Aoki T, Yanagida T, Ide T. 2010. Rearrangements in the KcsA cytoplasmic domain underlie its gating. J. Biol. Chem. 285:3777-783.
94. Yi M, Cross TA, Zhou HX. 2009. Conformational heterogeneity of the M2 proton channel and a structural model for channel activation. Proc. Natl. Acad. Sci. USA 106:13311-316.
95. KhuranaE, Dal Peraro M, DeVaneR, Vemparala S, DeGradoWF, Klein ML. 2009. Molecular dynamics calculations suggest a conduction mechanism for the M2 proton channel from influenza A virus. Proc. Natl. Acad. Sci. USA 106:1069-074.
96. Khurana E, Devane RH, Dal Peraro M, Klein ML. 2011. Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus. Biochim. Biophys. Acta. 1808(2):530-537.
97. Luo W, Hong M. 2010. Conformational changes of an ion channel detected through water-protein interactions using solid-state NMR spectroscopy. J. Am. Chem. Soc. 132:2378-384.
98. HuF, Luo W, Cady SD, HongM. 2010. Conformational plasticity of the influenza AM2 transmembrane helix in lipid bilayers under varying pH, drug binding, and membrane thickness Biochim. Biophys. Acta 1808:415-423.
99. Cross TA, Sharma M, Yi M, Zhou HX. 2011. Influence of solubilizing environments on membrane protein structures. Trends Biochem. Sci. 36(2):117-125.
100. Bhate MP, Wylie BJ, Tian L, McDermott AE. 2010. Conformational dynamics in the selectivity filter of KcsA in response to potassium ion concentration. J. Mol. Biol. 401:155-166.
101. Hu J, Fu R, Cross TA. 2007. The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain. Biophys. J. 93:276-283. (Pubitemid 47041672)
102. Li C, Qin H, Gao FP, Cross TA. 2007. Solid-state NMR characterization of conformational plasticity within the transmembrane domain of the influenza A M2 proton channel. Biochim. Biophys. Acta 1768:3162-170. (Pubitemid 350236087)
103. Boehr DD, McElheny D, Dyson HJ, Wright PE. 2010. Millisecond timescale fluctuations in dihydrofolate reductase are exquisitely sensitive to the bound ligands. Proc. Natl. Acad. Sci. USA 107:1373-378.
104. Yohannan S, Hu Y, Zhou Y. 2007. Crystallographic study of the tetrabutylammonium block to the KcsA K+ channel. J. Mol. Biol. 366:806-814. (Pubitemid 46175877)
105. YellenG. 1987. Permeation in potassium channels: implications for channel structure. Annu. Rev. Biophys. Biophys. Chem. 16:227-246.
106. Baukrowitz T, Yellen G. 1996. Two functionally distinct subsites for the binding of internal blockers to the pore of voltage-activated K+ channels. Proc. Natl. Acad. Sci. USA 93:13357-361. (Pubitemid 26382820)
107. Gandhi CS, Shuck K, Lear JD, Dieckmann GR, DeGrado WF, et al. 1999. Cu(II) inhibition of the proton translocation machinery of the influenza A virus M2 protein. J. Biol. Chem. 274:5474-482. (Pubitemid 29109194)
108. Balannik V, Wang J, Ohigashi Y, Jing X, Magavern E, et al. 2009. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus. Biochemistry 48:11872-882.
109. Wang J, Cady SD, Balannik V, Pinto LH, DeGrado WF, HongM. 2009. Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus. J. Am. Chem. Soc. 131:8066-076.
110. Luo BH, Carman CV, Springer TA. 2007. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25:619-647. (Pubitemid 46697919)
111. Bennett JS, Moore DT. 2010. Regulation of platelet beta 3 integrins. Haematologica 95:1049-051.
112. Bennett JS, Berger BW, Billings PC. 2009. The structure and function of platelet integrins. J. Thromb. Haemost. 7(Suppl. 1):200-5.
113. Shattil SJ, Kim C, Ginsberg MH. 2010. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 11:288-300.
114. Cox D, Brennan M, Moran N. 2010. Integrins as therapeutic targets: lessons and opportunities. Nat. Rev. Drug Discov. 9:804-820.
115. Luo BH, Carman CV, Takagi J, Springer TA. 2005. Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc. Natl. Acad. Sci. USA 102:3679-684. (Pubitemid 40354671)
116. KimM, Carman CV, Springer TA. 2003. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301:1720-725. (Pubitemid 37174365)
117. Berger BW, Kulp DW, Span LM, DeGrado JL, Billings PC, et al. 2010. Consensus motif for integrin transmembrane helix association. Proc. Natl. Acad. Sci. USA 107:703-8.
118. Zhu J, Luo BH, Barth P, Schonbrun J, Baker D, Springer TA. 2009. The structure of a receptor with two associating transmembrane domains on the cell surface: integrin alphaIIbbeta3. Mol. Cell 34:234-249.
119. Luo BH, Springer TA, Takagi J. 2004. A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol. 2:e153.
120. Zhu J, Carman CV, Kim M, Shimaoka M, Springer TA, Luo BH. 2007. Requirement of alpha and beta subunit transmembrane helix separation for integrin outside-in signaling. Blood 110:2475-483. (Pubitemid 47523169)
121. Metcalf DG, KulpDW, Bennett JS, DeGrado WF. 2009. Multiple approaches converge on the structure of the integrin alphaIIb/beta3 transmembrane heterodimer. J. Mol. Biol. 392:1087-101.
122. Yang J, Ma YQ, Page RC, Misra S, Plow EF, Qin J. 2009. Structure of an integrin alphaIIb beta3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation. Proc. Natl. Acad. Sci. USA 106:17729-734.
123. Xie C, Zhu J, Chen X, Mi L, Nishida N, Springer TA. 2010. Structure of an integrin with an alphaI domain, complement receptor type 4. EMBO J. 29:666-679.
124. Donald JE, Zhu H, Litvinov RI, DeGrado WF, Bennett JS. 2010. Identification of interacting hotspots in the beta3 integrin stalk using comprehensive interface design. J. Biol. Chem. 285:38658-665.
125. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. 2004. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432:59-67. (Pubitemid 39490825)
126. Xiong JP, Stehle T, Zhang R, Joachimiak A, Frech M, et al. 2002. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 296:151-155. (Pubitemid 34280076)
127. Shimaoka M, Salas A, Yang W, Weitz-Schmidt G, Springer TA. 2003. Small molecule integrin antagonists that bind to the beta2 subunit I-like domain and activate signals in one direction and block them in the other. Immunity 19:391-402. (Pubitemid 37153415)
128. Chen X, Xie C, Nishida N, Li Z, Walz T, Springer TA. 2010. Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2. Proc. Natl. Acad. Sci. USA 107:14727-732.
129. Vinogradova O, Velyvis A, Velyviene A, Hu B, Haas T, et al. 2002. A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face. Cell 110:587-597. (Pubitemid 35247839)
130. Weljie AM, Hwang PM, Vogel HJ. 2002. Solution structures of the cytoplasmic tail complex from platelet integrin alpha IIb- and beta 3-subunits. Proc. Natl. Acad. Sci. USA 99:5878-883. (Pubitemid 34493233)
131. Ulmer TS, Yaspan B, Ginsberg MH, Campbell ID. 2001. NMR analysis of structure and dynamics of the cytosolic tails of integrin alpha IIb beta 3 in aqueous solution. Biochemistry 40:7498-508. (Pubitemid 32578014)
132. Vinogradova O, Vaynberg J, Kong X, Haas TA, Plow EF, Qin J. 2004. Membrane-mediated structural transitions at the cytoplasmic face during integrin activation. Proc. Natl. Acad. Sci. USA 101:4094-099. (Pubitemid 38405889)
133. Metcalf DG, MooreDT, WuY, Kielec JM, MolnarK, et al. 2010.NMRanalysis of theαIIbβ3 cytoplasmic interaction suggests a mechanism for integrin regulation. Proc. Natl. Acad. Sci. USA 107:22481-486.
134. MoserM, LegateKR, Zent R, Fassler R. 2009. The tail of integrins, talin, and kindlins. Science 324:895-899.
135. Shimaoka M, Xiao T, Liu JH, Yang Y, Dong Y, et al. 2003. Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112:99-111. (Pubitemid 36106422)
136. Hantgan RR, StahleMC.2009. Integrin priming dynamics:mechanisms of integrin antagonist-promoted alphaIIbbeta3:PAC-1 molecular recognition. Biochemistry 48:8355-365.
137. Hantgan RR, StahleMC, Lord ST. 2010. Dynamic regulation of fibrinogen: integrin alphaIIbbeta3 binding. Biochemistry 49:9217-225.
138. Puklin-Faucher E, Sheetz MP. 2009. The mechanical integrin cycle. J. Cell Sci. 122:179-186.
139. Friedland JC, Lee MH, Boettiger D. 2009. Mechanically activated integrin switch controls alpha5beta1 function. Science 323:642-644.
140. Wang X, Lupardus P, Laporte SL, Garcia KC. 2009. Structural biology of shared cytokine receptors. Annu. Rev. Immunol. 27:29-60.
141. Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141:1117-134.
142. Lohse MJ. 2010. Dimerization in GPCR mobility and signaling. Curr. Opin. Pharmacol. 10:53-58.
143. Chung I, Akita R, Vandlen R, Toomre D, Schlessinger J, Mellman I. 2010. Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464:783-787.
144. Alvarado D, Klein DE, Lemmon MA. 2010. Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell 142:568-579.
145. Ye F, Hu G, Taylor D, Ratnikov B, Bobkov AA, et al. 2010. Recreation of the terminal events in physiological integrin activation. J. Cell. Biol. 188:157-173.
146. Ma YQ, Qin J, Wu C, Plow EF. 2008. Kindlin-2 (Mig-2): a co-activator of beta3 integrins. J. Cell. Biol. 181:439-446. (Pubitemid 351645034)
147. Harburger DS, Bouaouina M, Calderwood DA. 2009. Kindlin-1 and -2 directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrin-specific activation effects. J. Biol. Chem. 284:11485-497.
148. Bledzka K, Bialkowska K, Nie H, Qin J, Byzova T, et al. 2010. Tyrosine phosphorylation of integrin beta3 regulates kindlin-2 binding and integrin activation. J. Biol. Chem. 285:30370-374.
149. Anthis NJ, Haling JR, Oxzley CL, Memo M, Wegener KL, et al. 2009. Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation. J. Biol. Chem. 284:36700-710.
150. Kiema T, Lad Y, Jiang P, Oxley CL, Baldassarre M, et al. 2006. The molecular basis of filamin binding to integrins and competition with talin. Mol. Cell 21:337-347. (Pubitemid 43163529)
151. Takala H, Nurminen E, Nurmi SM, AatonenM, Strandin T, et al. 2008. Beta2 integrin phosphorylation on Thr758 acts as a molecular switch to regulate 14-3-3 and filamin binding. Blood 112:1853-62